Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
- PMID: 25066289
- DOI: 10.1111/bjd.13074
Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
Comment on
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.N Engl J Med. 2013 Mar 7;368(10):924-35. doi: 10.1056/NEJMoa1215372. Epub 2013 Feb 24. N Engl J Med. 2013. PMID: 23432142 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
